Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
CHRO - Chromocell Therapeutics Corp. - Stock Price Chart
TickerCHRO [AMEX]
CompanyChromocell Therapeutics Corp.
CountryUSA
IndustryBiotechnology
Market Cap7.90MEPS (ttm)-1.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B6.99EPS Q/Q-165.10%
Dividend-Sales Q/Q-
Insider Own72.86%Inst Own9.90%
Insider Trans0.00%Inst Trans-
Short Float0.01%EarningsMay 29
Analyst Recom1.00Target Price8.50
Avg Volume22.94K52W Range1.21 - 6.00
Chromocell Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. The company was founded on March 19, 2021 and is headquartered in Freehold, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davis Todd CDirectorFeb 21 '24Option Exercise4.8029,167140,00229,167Feb 23 05:15 PM
Friedberg Ezra MDirectorFeb 21 '24Option Exercise4.8020,64199,077520,719Feb 23 05:12 PM
FBLG - FibroBiologics Inc - Stock Price Chart
TickerFBLG [NASD]
CompanyFibroBiologics Inc
CountryUSA
IndustryBiotechnology
Market Cap155.09MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-437.63%
Dividend-Sales Q/Q-
Insider Own18.87%Inst Own1.47%
Insider Trans0.00%Inst Trans-
Short Float0.52%Earnings-
Analyst Recom-Target Price-
Avg Volume133.40K52W Range5.30 - 55.00
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm's product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O'Heeron on April 8, 2021 and is headquartered in Houston, TX.
BCDA - BioCardia Inc. - Stock Price Chart
TickerBCDA [NASD]
CompanyBioCardia Inc.
CountryUSA
IndustryBiotechnology
Market Cap5.46MEPS (ttm)-6.97
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y30.13%
P/S11.62EPS next 5Y-
P/B-EPS Q/Q48.01%
Dividend-Sales Q/Q-14.06%
Insider Own29.16%Inst Own7.13%
Insider Trans-3.09%Inst Trans-
Short Float1.63%EarningsMay 14/a
Analyst Recom2.00Target Price60.00
Avg Volume130.26K52W Range3.20 - 43.80
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Altman PeterPresident and CEOJun 14 '24Buy3.525001,76038,745Jun 17 07:00 AM
Altman PeterPresident and CEOJun 10 '24Buy3.361,0003,36038,245Jun 12 07:00 AM
Altman PeterPresident and CEOApr 19 '24Buy0.372,7501,013558,697Apr 19 05:38 PM
Altman PeterPresident and CEOMar 28 '24Buy0.39500195555,947Mar 28 07:33 PM
Altman PeterPresident and CEOFeb 13 '24Buy0.46108,10850,000555,447Feb 15 07:00 AM
LPA - Logistic Properties of the Americas - Stock Price Chart
TickerLPA [AMEX]
CompanyLogistic Properties of the Americas
CountryUSA
IndustryReal Estate - Development
Market Cap507.36MEPS (ttm)0.05
P/E332.64EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.68EPS Q/Q-133.94%
Dividend-Sales Q/Q-
Insider Own91.27%Inst Own0.68%
Insider Trans0.00%Inst Trans333.53%
Short Float1.77%Earnings-
Analyst Recom-Target Price-
Avg Volume88.23K52W Range5.59 - 525.00
Logistic Properties of the Americas develops, builds and operates logistic real estate properties. The company was headquartered in San Rafael de Escazu, Costa Rica.
LRHC - La Rosa Holdings Corp - Stock Price Chart
TickerLRHC [NASD]
CompanyLa Rosa Holdings Corp
CountryUSA
IndustryReal Estate Services
Market Cap21.33MEPS (ttm)-0.98
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.55EPS next 5Y-
P/B3.60EPS Q/Q-327.60%
Dividend-Sales Q/Q116.64%
Insider Own46.28%Inst Own0.12%
Insider Trans0.00%Inst Trans-
Short Float0.22%Earnings-
Analyst Recom-Target Price-
Avg Volume1.58M52W Range0.52 - 5.53
La Rosa Holdings Corp. operates as a holding company, which provides real estate brokerage services. It sells technology-based products and services primarily to sales agents and the sales agents associated with its franchisees. The company operates through the five reportable segments: Residential Real Estate Brokerage Services, Franchising Services, Coaching Services, Property Management, and Commercial Real Estate Brokerage Services. The Residential Real Estate Brokerage Services segment engages in the real estate brokerage business. The Franchising Services segment engages in the franchising of real estate brokerage agencies. The Coaching Services segment engages in the delivery of coaching services to its brokers and franchisee's brokers. The Property Management segment engages in the training of its sales agents to provide residential property management services to owners of single family residential properties. The Commercial Real Estate Brokerage Services segment engages in the brokering of the sale of commercial real estate. La Rosa Holdings was founded by Joseph La Rosa in 2004 and is headquartered in Celebration, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LA ROSA JOSEPHCHIEF EXECUTIVE OFFICEROct 12 '23Option Exercise3.71437,4281,620,9985,837,428Oct 16 09:51 PM
LA ROSA JOSEPHCHIEF EXECUTIVE OFFICEROct 12 '23Option Exercise5.002851,4256,737,713Oct 16 09:51 PM
SANTOS ALEXCHIEF TECHNOLOGY OFFICEROct 09 '23Option Exercise5.005,31626,5809,316Oct 10 05:12 PM
SCLX - Scilex Holding Company - Stock Price Chart
TickerSCLX [NASD]
CompanyScilex Holding Company
CountryUSA
IndustryDrug Manufacturers - General
Market Cap317.08MEPS (ttm)-0.89
P/E-EPS this Y58.01%
Forward P/E-EPS next Y9.46%
PEG-EPS past 5Y-
P/S6.74EPS next 5Y-
P/B-EPS Q/Q-9.63%
Dividend-Sales Q/Q2.85%
Insider Own34.74%Inst Own15.96%
Insider Trans0.42%Inst Trans-8.47%
Short Float5.98%EarningsMay 29
Analyst Recom1.00Target Price7.25
Avg Volume1.08M52W Range0.73 - 7.30
Jun-20-24 09:00AM Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC. (GlobeNewswire) +7.10%
Jun-14-24 01:41PM Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA ) in Lumbosacral Radicular Pain (Sciatica) (GlobeNewswire) +8.05%
Jun-13-24 09:00AM Scilex Holding Company to Present Poster on ELYXYB (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024 (GlobeNewswire)
Jun-11-24 07:20PM Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies (GlobeNewswire) +18.75% +8.27%
09:00AM Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA (GlobeNewswire)
Jun-10-24 11:49AM Scilex Holding Company Announces Stocking of GLOPERBA is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S. (GlobeNewswire)
Jun-06-24 02:56PM Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba which will be launched in the US in the week of June 10th 2024 (GlobeNewswire) +9.26%
May-30-24 01:19PM Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company (GlobeNewswire)
May-24-24 01:40PM Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index (GlobeNewswire)
09:00AM Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company (GlobeNewswire)
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHAH JAISIMSee RemarksJun 20 '24Option Exercise1.7314,00024,22047,333Jun 20 04:43 PM
Chun JayDirectorJun 20 '24Option Exercise1.415,0007,050107,500Jun 20 04:49 PM
Wu Yue AlexanderDirectorJun 20 '24Option Exercise1.415,0007,0505,000Jun 20 06:07 PM
Ma Stephen HoiChief Financial OfficerJun 20 '24Option Exercise1.412,0002,82016,140Jun 20 04:54 PM
Ji HenryExecutive ChairpersonJun 18 '24Option Exercise1.416,0008,460311,273Jun 18 09:26 PM
ABL - Abacus Life Inc - Stock Price Chart
TickerABL [NASD]
CompanyAbacus Life Inc
CountryUSA
IndustryInsurance - Life
Market Cap557.27MEPS (ttm)0.03
P/E309.96EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S7.17EPS next 5Y-
P/B3.32EPS Q/Q-113.33%
Dividend-Sales Q/Q129.12%
Insider Own96.78%Inst Own0.87%
Insider Trans0.00%Inst Trans-24.63%
Short Float18.09%EarningsMay 29
Analyst Recom1.00Target Price16.00
Avg Volume27.14K52W Range5.47 - 13.25
Abacus Life, Inc. is an integrated alternative asset manager, which engages in the business of investing in inforce life insurance products. The firm is involved in purchasing outstanding life insurance policies to connect buyers and sellers through an origination process. It operates through the following segments: Portfolio Servicing, Active Management, and Originations. The Portfolio servicing segment offers policy services to customers on a contract basis. The Active Management segment is involved in buying, selling, and trading policies and maintaining policies through to death benefit. The Origination segment originates life insurance policy settlement contracts as a licensed life settlement provider on behalf of third-party institutional investors interested in investing in the life settlement asset class. The company was founded by Matthew Ganovsky, Kevin Scott Kirby, and Todd Sean McNealy on May 22, 2020 and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gusky Adam SamuelDirectorNov 17 '23Buy6.025,00030,10022,718Nov 20 06:57 PM
Gusky Adam SamuelDirectorNov 16 '23Buy6.167,20044,38117,718Nov 20 06:57 PM
McNealy SeanCo-Founder and PresidentNov 16 '23Buy6.173001,85112,593,550Nov 20 06:15 PM
Schulte Mary BethDirectorAug 23 '23Buy7.7313,000100,50813,000Aug 24 04:04 PM
BJDX - Bluejay Diagnostics Inc - Stock Price Chart
TickerBJDX [NASD]
CompanyBluejay Diagnostics Inc
CountryUSA
IndustryMedical Devices
Market Cap1.69MEPS (ttm)-61.43
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-62.82%
P/S-EPS next 5Y-
P/B0.30EPS Q/Q60.41%
Dividend-Sales Q/Q-
Insider Own-Inst Own9.50%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom3.00Target Price256.00
Avg Volume45.31K52W Range2.62 - 111.84
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dey IndranilPresident and CEODec 13 '23Buy3.275001,63528,526Dec 14 04:16 PM
Dey SvetlanaDirectorDec 13 '23Buy3.075001,5351,500Dec 14 04:17 PM
RMBL - RumbleON Inc - Stock Price Chart
TickerRMBL [NASD]
CompanyRumbleON Inc
CountryUSA
IndustryAuto & Truck Dealerships
Market Cap157.08MEPS (ttm)-9.92
P/E-EPS this Y94.81%
Forward P/E79.55EPS next Y108.92%
PEG-EPS past 5Y18.58%
P/S0.12EPS next 5Y25.00%
P/B1.69EPS Q/Q71.86%
Dividend-Sales Q/Q-11.12%
Insider Own37.37%Inst Own45.50%
Insider Trans0.00%Inst Trans2.08%
Short Float2.97%EarningsMay 08/b
Analyst Recom1.60Target Price9.50
Avg Volume114.71K52W Range4.82 - 12.85
RumbleOn, Inc. engages in the provision of motor vehicle dealer and e-commerce platforms. It operates through the following segments: Powersports, Automotive, and Vehicle Logistics and Transportation. The Powersports segment distributes pre-owned motorcycles and powersports vehicles. The Automotive segment focuses on the distribution of pre-owned cars and trucks. The Vehicle Logistics and Transportation segment offers nationwide automotive transportation services between dealerships and auctions. The company was founded by Matthew A. Lane, Marshall Chesrown, and Steven Richard Berrard on October 24, 2013 and is headquartered in Irving, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stone House Capital ManagementMember of a 10% GroupDec 08 '23Buy5.501,721,6459,469,0486,398,144Dec 12 04:05 PM
Tkach Mark10% OwnerDec 08 '23Buy5.50860,8224,734,5216,402,566Dec 12 09:36 PM
Coulter WilliamDirectorDec 08 '23Buy5.50860,8224,734,5216,321,489Dec 12 09:30 PM
Coulter WilliamDirectorDec 05 '23Option Exercise5.502,827,03715,548,7045,460,667Dec 07 09:32 PM
Tkach Mark10% OwnerDec 05 '23Option Exercise5.502,794,27815,368,5295,476,431Dec 07 09:30 PM
BKKT - Bakkt Holdings Inc - Stock Price Chart
TickerBKKT [NYSE, RUT]
CompanyBakkt Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap93.45MEPS (ttm)-14.07
P/E-EPS this Y67.51%
Forward P/E-EPS next Y32.21%
PEG-EPS past 5Y-
P/S0.06EPS next 5Y-
P/B1.55EPS Q/Q56.48%
Dividend-Sales Q/Q6480.79%
Insider Own7.15%Inst Own23.83%
Insider Trans335.36%Inst Trans67.94%
Short Float16.55%EarningsMay 15/a
Analyst Recom2.33Target Price16.85
Avg Volume367.34K52W Range5.57 - 68.75
Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Intercontinental Exchange, Inc10% OwnerApr 25 '24Buy0.87350,880304,213649,934Apr 29 09:11 PM
Intercontinental Exchange, Inc10% OwnerMar 04 '24Buy0.872,762,0092,394,6627,476,345Mar 04 05:34 PM
D'Annunzio MarcGeneral Counsel & SecretaryFeb 23 '24Sale0.8850,24744,047566,630Feb 26 09:28 PM
D'Annunzio MarcGeneral Counsel & SecretaryFeb 08 '24Sale0.9819,32918,927638,157Feb 09 09:13 PM
D'Annunzio MarcGeneral Counsel & SecretaryJan 25 '24Sale1.2742,80754,249667,320Jan 29 07:19 PM
1234567891020